We are live on ! Find out more
BOUT icon

CapForce IBD Breakout Opportunities ETF

14 hedge funds and large institutions have $2.52M invested in CapForce IBD Breakout Opportunities ETF in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

17% more funds holding

Funds holding: 1214 (+2)

9% more capital invested

Capital invested by funds: $2.31M → $2.52M (+$205K)

2.81% more ownership

Funds ownership: 11.95%14.77% (+2.8%)

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

Holders
14
Holders Change
+2
Holders Change %
+16.67%
% of All Funds
0.22%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
2
Reduced
3
Closed
1
Calls
Puts
Net Calls
Net Calls Change

BOUT Hedge Fund Activity: Q1 2022 in Review

14 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in CapForce IBD Breakout Opportunities ETF (BOUT) for Q1 2022, worth a combined $2.52M — up 8.9% from $2.31M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new BOUT positions and 1 closed out — a net gain of 2 holders — while 2 added to existing stakes and 3 trimmed.

The largest buyer was Susquehanna International Group, adding an estimated $276K. The largest seller was Cambridge Investment Research Advisors, exiting entirely with an estimated $205K sold.

  • 14 institutional investors held CapForce IBD Breakout Opportunities ETF (BOUT) as of Q1 2022, up from 12 in Q4 2021.
  • Funds reported $2.52M of CapForce IBD Breakout Opportunities ETF stock for Q1 2022, up 8.9% quarter-over-quarter.
  • 3 funds opened new CapForce IBD Breakout Opportunities ETF positions in Q1 2022 and 1 closed out, a net change of +2 holders.
  • The largest CapForce IBD Breakout Opportunities ETF buyer in Q1 2022 was Susquehanna International Group, an estimated $276K added.
  • The largest CapForce IBD Breakout Opportunities ETF seller in Q1 2022 was Cambridge Investment Research Advisors, an estimated $205K sold.

Based on aggregated 13F filings for Q1 2022.